Promoter Stake Climbs To 62.57% In This Chemical Stock After Stock Split & Bonus Issue; Here’s How

Following the conversion of 13,75,000 warrants issued on a preferential basis to both promoter and non-promoter investors, Fineotex Chemical Limited has announced that its Fund Raising Committee, at a meeting on November 21, 2025, approved the allocation of 1,37,50,000 equity shares of face value Rs 1 each at an issue price of Rs 34.60 per share, including Rs 33.60 premium. After four allottees paid the remaining sum of Rs 35,68,12,500, or 75% of the warrant issue price of Rs 346 apiece, the conversion was completed.

As a result of this allocation, the company's paid-up capital rose to Rs 115.95 crore, consisting of 115.95 crore equity shares. Currently, 62.57% of the shares are owned by promoters and 37.43% by non-promoters. Adjustments were made in compliance with SEBI standards and following the recent share split and bonus issue authorized on October 25, 2025.

The new shares will rank pari-passu with existing shares. Additionally, the company revealed that 12,51,600 of the 26,26,600 warrants that were first distributed on May 22, 2024, were no longer valid and that the subscription value of Rs 32,47,90,200 had been forfeited in accordance with regulatory regulations.

With a record date of October 31, 2025, Fineotex Chemical accomplished a 4:1 bonus share issuance and a 1:2 stock split. Each Rs 2 share was split into two Rs 1 shares under the stock split, and each shareholder received four free shares under the bonus issue. An investor who had one share before the record date would have five shares overall following both actions: one original share that had been split into two shares and four bonus shares.

With a 0.5% QoQ rise and a modest rise in consolidated revenue from operations to Rs 137.71 crore, Fineotex Chemical Limited performed well in Q2 FY26. Gross profit improved to Rs 52.95 crore, up 15.2% QoQ, thanks to improved cost savings; the gross margin climbed to 38.45% from 33.53% in Q1. EBITDA jumped by 23.12% QoQ to Rs 31.03 crore as a result of strong operational performance, and EBITDA margin improved by 415 basis points to 22.53%

.Net profit jumped by 4.2% QoQ to Rs 26.08 crore after profit before tax climbed by 12.4% QoQ to Rs 35.39 crore. Basic EPS improved to Rs 2.27 from Rs 2.18 in Q1, while PAT margin was strong at 18.94%. With strong margins and strict cost management, revenue on an H1 basis was Rs 291.64 crore and PAT was Rs 51.10 crore.

With total assets increasing to Rs 877.60 crore from ₹814.63 crore as of March 31, 2025, Fineotex Chemical Limited reported an excellent balance sheet position as of September 30, 2025. This rise was primarily driven by greater current assets and ongoing investments. Retained earnings growth helped shareholders' funds grow from Rs 738.87 crore to Rs 787.76 crore.

A rise in deferred tax obligations caused non-current liabilities to climb to Rs 11.78 crore from Rs 8.66 crore, while increasing trade payables and other current liabilities caused current liabilities to rise to Rs 78.06 crore from Rs 67.10 crore.

Due to a growth in financial investments and property, plant, and equipment, non-current assets climbed to Rs 564.29 crore. With growing trade receivables of Rs 132.38 crore, cash and cash equivalents of Rs 46.29 crore, and bank balances of Rs 22.29 crore, current assets climbed dramatically to Rs 313.30 crore from Rs 260.93 crore.

The company remains well-capitalised, maintaining a robust equity base and sufficient liquidity to support future growth.